In Reply: Statistical Power to Detect an Association Between Guideline-based Palivizumab Administration and Hospitalizations for Respiratory Syncytial Virus Infections
Pediatr Infect Dis J
.
2017 Mar;36(3):348-349.
doi: 10.1097/INF.0000000000001433.
Authors
Carlina J Grindeland
1
,
David D Leedahl
Affiliation
1
Department of Pharmacy, Sanford Medical Center, Fargo, North Dakota.
PMID:
28187117
DOI:
10.1097/INF.0000000000001433
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal
Antiviral Agents
Hospitalization
Humans
Infant
Palivizumab*
Respiratory Syncytial Virus Infections*
Substances
Antibodies, Monoclonal
Antiviral Agents
Palivizumab